Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
Conditions: C3 Glomerulopathy; Membranoproliferative Glomerulonephritis; Complement Abnormality; Dense Deposit Disease; C3 Glomerulonephritis Interventions: Drug: Aliskiren; Drug: Enalapril Sponsor: Region Skane Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials